Clinical Trial Update: Docetaxel, Bevacizumab and Androgen Deprivation Therapy After Definitive Local Therapy for Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial in prostate cancer after definitive local therapy evaluating docetaxel, bevacizumab, and androgen deprivation therapy has completed with results p…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Bevacizumab (bevacizumab)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Dana-Farber Cancer Institute | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED | Results posted: 2015-08-26